Centenarian Biology: What People Who Live to 100 Actually Have in Common
Centenarian research — the systematic study of people who live to age 100 or beyond in good health — offers a different and complementary perspective on longevity compared to epidemiological risk factor studies. Rather than identifying what kills people earlier, centenarian studies ask what protects people against the diseases of aging for an extraordinarily long time. The findings are both predictable and surprising.
- The most consistent biological finding across multiple independent centenarian cohort studies is not a specific genetic variant or a specific diet — it is the maintenance of insulin sensitivity and low metabolic disease burden into extreme old age. Centenarians overwhelmingly show favorable metabolic profiles: low fasting insulin, low visceral fat, high adiponectin, and minimal lifetime exposure to insulin resistance and type 2 diabetes.
- Centenarians tend to have lower IGF-1 levels than age-matched non-centenarians in multiple studies — consistent with the mechanistic evidence from model organisms that reduced IGF-1/GH signaling extends lifespan. This finding does not mean IGF-1 reduction per se promotes longevity; it likely reflects the metabolic phenotype of individuals who have maintained low body fat, low insulin, and low caloric intake across their lifespans.
- The CETP (cholesterol ester transfer protein) variant enriched in Ashkenazi Jewish centenarians studied by Nir Barzilai produces larger, more buoyant HDL particles and LDL particles — a lipid phenotype associated with substantially lower cardiovascular risk and longer lifespan in this population. This finding has practical implications: particle size and HDL functionality may be more important longevity biomarkers than HDL-C alone.
- Centenarians consistently show better preserved immune function than age-matched non-centenarians — maintained NK cell activity, preserved T cell repertoire diversity, and lower chronic inflammatory biomarkers. This immune competence is both a consequence of their favorable metabolic and lifestyle factors and an independent longevity factor that allows them to resist infections and maintain cancer immune surveillance into extreme old age.
- The psychological profile of centenarians studied across multiple cultures and cohorts shares consistent features: positive affect, emotional resilience, lower neuroticism, strong sense of purpose, and active social engagement. Whether these traits are causes or consequences of exceptional longevity — or both — is debated, but the consistency of the association across cultures suggests a genuine biological link between psychological resilience and longevity biology.
Centenarian research — studying the small fraction (approximately 1 in 10,000 in developed countries) of individuals who live to age 100 or beyond — offers a research window that epidemiological studies of risk factors and mortality cannot provide. Rather than studying what kills people, centenarian research studies what protects people from dying — across a century of biological challenges, disease exposures, and environmental stressors. The findings from the New England Centenarian Study, the Longevity Genes Project, the Okinawa Centenarian Study, and several European cohorts have produced converging insights about the biology of exceptional longevity.1
The Centenarian Metabolic Profile
The most consistent finding across independent centenarian cohort studies is the maintenance of metabolic health and insulin sensitivity into extreme old age. Centenarians overwhelmingly demonstrate: low fasting insulin and HOMA-IR, low visceral adiposity, high circulating adiponectin (the anti-inflammatory adipokine secreted by metabolically healthy fat tissue), low triglycerides, and minimal lifetime exposure to type 2 diabetes. In the New England Centenarian Study, fewer than 10 percent of centenarians had a history of diabetes — dramatically below the general population prevalence.2
This metabolic advantage is partly genetic (variants in insulin/IGF-1 signaling pathway genes are enriched in centenarians) and partly behavioral (lifetime patterns of physical activity, moderate caloric intake, and plant-rich diet are consistently reported in centenarian populations). Separating the genetic from the behavioral contribution is methodologically challenging, but the metabolic phenotype itself — maintained insulin sensitivity and low visceral fat — appears to be the most consistent biological signature of exceptional longevity across populations.
IGF-1 and the Growth Hormone Axis
Multiple centenarian cohort studies have found that long-lived individuals tend to have lower circulating IGF-1 levels than age-matched non-centenarians. This finding is consistent with the mechanistic evidence from model organisms: reduced insulin/IGF-1 signaling is the most robust longevity-extending intervention identified across yeast, worms, flies, and mice, and mutations in the insulin/IGF-1 signaling pathway consistently extend lifespan in every model organism studied. The paradox — that IGF-1 is required for normal growth, tissue maintenance, and muscle function, yet lower IGF-1 associates with longer life — likely reflects the difference between physiological IGF-1 (adequate for tissue maintenance, produced by healthy liver in a metabolically normal individual) and supraphysiological IGF-1 (driving excess cellular proliferation and potentially cancer-promoting mTOR activation).3
The CETP Finding and Lipoprotein Quality
Nir Barzilai's Longevity Genes Project at Albert Einstein College of Medicine, which recruited Ashkenazi Jewish centenarians and their offspring, identified a variant in the CETP gene as one of the most consistently enriched genetic findings in this population. CETP (cholesterol ester transfer protein) facilitates the transfer of cholesterol esters from HDL to other lipoproteins. Loss-of-function CETP variants produce larger, more buoyant HDL particles and larger LDL particles — a lipoprotein size phenotype associated with dramatically lower cardiovascular risk. Drugs designed to mimic this genetic effect (CETP inhibitors including anacetrapib and evacetrapib) have had mixed results in trials, but the genetic finding establishes that lipoprotein particle size and HDL functionality — not merely HDL-C concentration — are important longevity biomarkers.4
Psychological Resilience: The Consistent Cross-Cultural Finding
Centenarian studies across Japan, the United States, Europe, and Sardinia consistently find that centenarians share certain psychological characteristics: positive emotional affect, high resilience in the face of adversity, lower scores on neuroticism (a personality dimension reflecting emotional instability and anxiety), strong sense of purpose and meaning, and active social engagement. The OCEAN study of Sardinian centenarians found that conscientiousness — the tendency toward self-discipline, organization, and goal-directed behavior — was the personality trait most consistently associated with exceptional longevity, with a biological mechanism likely operating through better lifetime health behaviors and lower HPA axis reactivity.5
Whether these psychological traits cause longevity (through their effects on HPA axis regulation, health behavior, and social connection biology) or are consequences of selective survival (psychologically resilient people surviving traumatic events that eliminate their less resilient peers) is difficult to disentangle. The most likely answer is both: psychological resilience provides biological protection through multiple mechanisms, and the experience of outliving one's cohort selects for individuals with inherent stress-buffering capacity.
References
- 1Perls TT, et al. "Life-long sustained mortality advantage of siblings of centenarians." PNAS. 2002;99(12):8442-8447. [PubMed]
- 2Terry DF, et al. "Cardiovascular disease delay in centenarian offspring: role of heat shock proteins." Annals of the New York Academy of Sciences. 2004;1019:502-505. [PubMed]
- 3Suh Y, et al. "Functionally significant insulin-like growth factor I receptor mutations in centenarians." PNAS. 2008;105(9):3438-3442. [PubMed]
- 4Barzilai N, et al. "Unique lipoprotein phenotype and genotype associated with exceptional longevity." JAMA. 2003;290(15):2030-2040. [PubMed]
- 5Vaillant GE, Mukamal K. "Successful aging." American Journal of Psychiatry. 2001;158(6):839-847. [PubMed]